3,17-Diiodoandrosta-3,5,16-triene

3-Deoxy-3-acetylabiraterone-3-ene

Abiraterone acetate impurity intermediate

(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile

Pharmaceutical intermediate for alogliptin

N-4-Boc-N-1-Cbz-2-piperazine carboxylic acid

Pharmaceutical intermediate with orthogonal protecting groups

1-benzyl 2-methyl piperazine-1,2-dicarboxylate

Pharmaceutical intermediate

Methyl (S)-(1-((4-(3-(3-amino-5-chloro-2-fluorophenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate

pharmaceutical intermediate

[(8R,9S,10R,13S,14S)-10,13-dimethyl-2,7,8,9,11,12,14,15-octahydro-1H-cyclopenta[a]phenanthren-17-yl] trifluoromethanesulfonate

abiraterone acetate intermediate